Why Supernus Pharmaceuticals Stock Is Trading Higher Today

Supernus Pharmaceuticals SUPN shares are trading higher on Wednesday after the company reported better-than-expected third-quarter EPS and sales results. The company also raised its fiscal year 2020 sales guidance above analyst estimates.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. The majority of the revenue is generated from the sale of Trokendi XR.

Supernus Pharmaceuticals shares were trading up 19.47% at $21.68 on Wednesday. The stock has a 52-week high of $29.36 and a 52-week low of $13.12.

Loading...
Loading...
SUPN Logo
SUPNSupernus Pharmaceuticals Inc
$31.68-1.46%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
62.88
Growth
85.29
Quality
71.63
Value
60.05
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...